Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study

• Register: ClinicalTrials.gov
• Last refreshed on: 8 January 2024
• Main ID: NCT02872805
• Date of registration: 16/08/2016
• Prospective Registration: Yes
• Primary sponsor: University of Maryland, Baltimore
• Public title: Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study ADAPT
• Scientific title: Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study
• Date of first enrolment: November 1, 2019
• Target sample size: 298
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/ct2/show/NCT02872805
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Nigeria

Contacts

• Name: Vicki J Tepper, Ph.D.
• Affiliation: University of Maryland, Baltimore

Key inclusion & exclusion criteria

Inclusion Criteria:

- HIV infected patients between the ages of 16-19 years of age

- Patients who have been in care at the study site facility for a minimum of 1 year

- Patients who plan to transition their HIV care to one of the selected study sites

- Patients who are able to provide informed consent

Exclusion Criteria:

- HIV infected patients who have significant cognitive impairments(e.g., Mental
retardation)

- Patients planning to transition their HIV care outside the selected study facilities



Age minimum: 16 Years
Age maximum: 19 Years
Gender: All

Health Condition(s) or Problem(s) studied

AIDS

HIV

Intervention(s)

Other: PEPFAR Enhanced Standard of Care (PESCA)

Behavioral: Peer Transition Advocate (PTA)

Primary Outcome(s)

Viral load suppression [Time Frame: 12 months after transition occurs]

Successful transition [Time Frame: 9 months after transition occurs]

Secondary ID(s)

HP-00070099

Source(s) of Monetary Support

Please refer to primary and secondary sponsors